No COVID-19 Cases Detected Between April and September 2020 After Screening All 838 Admissions to a Maternity Unit in Poland

Background Between April and September 2020, there were <10 000 reported cases of COVID-19 in the Masovia district, Poland, and <1000 new cases daily in Poland. During this period, all new hospital admissions to a maternity unit of a teaching hospital in Warsaw were screened for the COVID-19 infection. This retrospective study presents the findings from the reverse transcription-polymerase chain reaction (RT-PCR) test for COVID-19. Material/Methods This study included 838 women admitted for delivery between April 20 and September 20, 2020. All the admitted women were assigned to a low-risk or a high-risk group for COVID-19 and underwent RT-PCR nasopharyngeal swab tests (GeneFinder™-COVID-19-Plus-RealAmpKit. OSANG Healthcare Co., Ltd., Gyeonggi-do, Korea) for COVID-19. The testing protocol included repeated testing in case of inconclusive results or negative results in the symptomatic patients. The maternal and neonatal data from these cases were collected and analyzed. Results All of the 838 women tested negative for COVID-19. Two women (0.24%) were classified as high risk for COVID-19. For 4 (0.48%) women, the results were initially inconclusive and negative when repeated. One hundred and eighty-one (21.5%) women presented with comorbidities, and 60 (7.2%) women were ≥40 years old. Conclusions The findings from this study show that between April and September 2020, there were no cases of COVID-19 infections at the maternity unit of a teaching hospital in Warsaw, Poland. However, the infection rates for COVID-19 across Europe continue to change. Testing protocols have been developed and established for all hospital admissions and it is anticipated that testing methods will become more rapid and accurate.

[1]  Uday Jain Personal Protective Equipment for COVID-19 , 2020, Journal of Surgery & Anesthesia Research.

[2]  M. Poljak,et al.  Usefulness of COVID-19 screen-and-test approach in pregnant women: an experience from a country with low COVID-19 burden , 2020, Journal of perinatal medicine.

[3]  J. Nien,et al.  Routine screening for SARS CoV-2 in unselected pregnant women at delivery , 2020, PloS one.

[4]  M. Tuuli,et al.  Universal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Testing Uptake in the Labor and Delivery Unit: Implications for Health Equity. , 2020, Obstetrics and gynecology.

[5]  Antonio Russo,et al.  Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review , 2020, Infection and drug resistance.

[6]  S. Unlu,et al.  The rate of SARS-CoV-2 positivity in asymptomatic pregnant women admitted to hospital for delivery: Experience of a pandemic center in Turkey , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[7]  M. Nakamura-Pereira,et al.  Worldwide maternal deaths due to COVID‐19: A brief review , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  S. Iliodromiti,et al.  Universal screening for SARS-CoV-2 in pregnant women at term admitted to an East London maternity unit , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[9]  A. Kurjak,et al.  Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine , 2020, Journal of perinatal medicine.

[10]  R. Delgado,et al.  Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid , 2020, Journal of perinatal medicine.

[11]  W. Oliveira,et al.  Maternal mortality and COVID-19 , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[12]  K. Bruxvoort,et al.  Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization , 2020, American Journal of Perinatology.

[13]  Felipe García,et al.  Coronavirus Disease 2019 in Pregnancy: A Clinical Management Protocol and Considerations for Practice , 2020, Fetal Diagnosis and Therapy.

[14]  S. Chauhan,et al.  Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection: A Systematic Review. , 2020, Obstetrics and gynecology.

[15]  P. Lagacé-Wiens,et al.  Diagnostic testing for SARS-CoV-2 , 2020, Canadian Medical Association Journal.

[16]  J. A. Mays,et al.  Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  B. Visseaux,et al.  The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  T. Metz Is Universal Testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Needed on All Labor and Delivery Units? , 2020, Obstetrics and gynecology.

[19]  M. Laranjo,et al.  Covid-19 during pregnancy: A case series from an universally tested population from the north of Portugal , 2020, European Journal of Obstetrics & Gynecology and Reproductive Biology.

[20]  L. Ramenghi,et al.  Universal SARS-CoV-2 testing of pregnant women admitted for delivery in two Italian regions. , 2020, American Journal of Obstetrics and Gynecology.

[21]  A. Frolova,et al.  False-Negative COVID-19 Testing: Considerations in Obstetrical Care , 2020, American Journal of Obstetrics & Gynecology MFM.

[22]  K. Aagaard,et al.  Maternal death due to COVID-19 , 2020, American Journal of Obstetrics and Gynecology.

[23]  A. Vintzileos,et al.  Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019 , 2020, American Journal of Obstetrics and Gynecology.

[24]  Dena Goffman,et al.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.

[25]  Sheng Zhang,et al.  False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence , 2020, Journal of medical virology.

[26]  F. Xue,et al.  ISIDOG Recommendations Concerning COVID-19 and Pregnancy , 2020, Diagnostics.

[27]  A. Khalil,et al.  Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis , 2020, American Journal of Obstetrics & Gynecology MFM.

[28]  R. Viner,et al.  Coronavirus in pregnancy and delivery: rapid review , 2020, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[29]  Russell S. Miller,et al.  COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals , 2020 .

[30]  World Health Organization,et al.  Transmission of SARS-CoV-2: implications for infection prevention precautions , 2020 .